Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment
Open Access
- 4 February 2025
- journal article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 55 (3) , 260-263
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Differential dynamics of TARC during JAK‐inhibitor therapy compared to biological therapies targeting type 2 inflammationClinical & Experimental Allergy, 2023
- Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitisAllergy, 2023
- Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsiesAllergy, 2021
- Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDermatitis®, 2021
- What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?Seminars in Immunopathology, 2021
- Research Techniques Made Simple: Stratum Corneum Tape StrippingJournal of Investigative Dermatology, 2021
- Biomarkers in atopic dermatitis—a review on behalf of the International Eczema CouncilJournal of Allergy and Clinical Immunology, 2021
- A minimally invasive tool to study immune response and skin barrier in children with atopic dermatitisBritish Journal of Dermatology, 2018
- Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodiesJournal of Immunological Methods, 2005